Cart
sales@molnova.com
Home - Products - Others - Other Targets - Lathyrol

Lathyrol

CAS No. 34420-19-4

Lathyrol( —— )

Catalog No. M18453 CAS No. 34420-19-4

Lathyrol diterpenes is a modulator of P-glycoprotein dependent multidrug resistance.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 41 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Lathyrol
  • Note
    Research use only, not for human use.
  • Brief Description
    Lathyrol diterpenes is a modulator of P-glycoprotein dependent multidrug resistance.
  • Description
    Lathyrol diterpenes is a modulator of P-glycoprotein dependent multidrug resistance.(In Vitro):Lathyrol exhibits reversal effects in MCF-7/ADR breast cancer cell lines in vitro.
  • In Vitro
    Lathyrol exhibits reversal effects in MCF-7/ADR breast cancer cell lines in vitro.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    34420-19-4
  • Formula Weight
    334.45
  • Molecular Formula
    C20H30O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL 299.00 mM
  • SMILES
    CC1CC2(C(C1O)C(C(=C)CCC3C(C3(C)C)C=C(C2=O)C)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Tormentic acid

    Tormentic acid is a natural product. It has anticancer, anti-inflammatory, anti-atherogenic , anti-allodynic, and hepatoprotective properties.

  • Harmidol hydrochlori...

    Harmalol hydrochloride is a β-carboline alkaloid that can be extracted from the seeds of Peganum harmala L. Harmalol hydrochloride is the major metabolite of Harmaline and significantly inhibits dioxin-mediated induction of CYP1A1 at both transcriptional and post-translational levels.

  • Atractylenolide III

    Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.

Sign In Join Free